Internal Medicine, Hematology & Oncology · Houston, TX
NPI
1497927123
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$25K
318 services
Medicare patients, 2024
140
Average age 72
Drug cost, 2024
$331K
213 prescriptions
Company payments, 2025
$13K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Arvind N Dasari was code 99214 (office e&m - established), 209 times for 110 patients. In total Arvind N Dasari billed 318 services in 12 codes, and Medicare paid $25K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-06-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 209 | 110 | $71.43 | $15K |
| 99214 Office E&M - Established | Office | 38 | 30 | $90.00 | $3,420 |
| 99204 Office E&M - New | Facility | 17 | 17 | $99.63 | $1,694 |
| 99205 Office E&M - New | Facility | 11 | 11 | $144.71 | $1,592 |
| 99215 Office E&M - Established | Facility | 11 | 11 | $80.37 | $884 |
By year: 2022 $22K for 278 services; 2023 $23K for 292 services; 2024 $25K for 318 services.
Medicare prescription drug claims, 2024
In 2024, the drug Arvind N Dasari prescribed most often to Medicare patients was Everolimus, with 42 prescriptions and refills. In total Arvind N Dasari wrote 213 Medicare prescriptions that cost $331K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Everolimus Generic | 42 | 42 | Under 11 | $250K |
| Ondansetron Hcl Generic | 30 | 30 | 18 | $167 |
| Prochlorperazine Maleate Generic | 26 | 26 | 19 | $393 |
| Loperamide Loperamide Hcl | 13 | 13 | Under 11 | $275 |
Brand drugs: 22 claims; generic drugs: 191 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Arvind N Dasari $13K ($13K in general payments such as food, travel and fees) from 11 companies. The largest payer was Genzyme Corporation with $3,855.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.